Symeres, a leading European CRO and CDMO, joins forces with Keensight Capital
Paris (France) – May 25th 2021 We are pleased to let you know that Keensight Capital, […]
The challenging and dynamic world of analytical chemistry
Organic chemistry at Symeres has been proactively accommodating recent developments in drug discovery. Today, we are […]
Ton Vries: The man behind the award
Ton’s days start with a 20 km bike ride from his farm in Drenthe to Symeres […]
Ton Vries Awards 2021 – Winner Announcement
The Ton Vries (Innovation) Award is new within Symeres and is dedicated to the person who, […]
Hepatic in vitro metabolism of peptides – An Interview with Ari Tolonen
The magazine Journal of Pharmaceutical and Biomedical Analysis recently published an article involving several of our Admescope […]
Future-proofing Your API
Wikipedia defines Future-proofing as: ‘the process of anticipating the future and developing methods of minimizing the […]
Scalable Synthesis of 17S-FD-895 – An Interview
The magazine Cell Reports Physical Science recently published an article involving several of our colleagues, called […]
An interview with Wolter ten Hoeve – co-founder of Syncom
An interview with a man who was involved with the establishment of Symeres, someone with a […]
Excellent HTS hits by design, not by accident
The identification of tractable chemical starting points in the drug discovery process relies on both the […]
